284 filings
Page 8 of 15
8-K
3jsa e8fq5x4zg7o
22 Dec 16
Other Events
12:00am
8-K
7bv hbqa58kmu7
1 Dec 16
Other Events
12:00am
8-K
h9qy8zd
9 Nov 16
Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update
12:00am
8-K
wk31qbdvf6cshkhy0i
3 Nov 16
Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer
12:00am
8-K
nda21hcpyjgxfd13n6
31 Oct 16
Galena Biopharma Announces Reverse Stock Split
12:00am
8-K
wpplq8k5dz
26 Oct 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
2nr ffzybl
6 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
l0qy5
8 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
8a704a6
23 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
w8uojhu6
22 Aug 16
Departure of Directors or Certain Officers
12:00am
8-K
6qfjg3owl
16 Aug 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
pfcz7e
12 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
m3lv5esi7o aoey0mmfp
9 Aug 16
Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update
12:00am
8-K
j88fraax xr
18 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
beef o8jae4a
18 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
c7i 66nzhr16jhqbnafs
12 Jul 16
Unregistered Sales of Equity Securities
12:00am
8-K
2uyy8ocx
8 Jul 16
Galena Biopharma Announces Pricing of Registered Direct Offering
12:00am
8-K
00nuzgkh
29 Jun 16
Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation
12:00am
8-K
15m4wjm4r7o
28 Jun 16
Other Events
12:00am
8-K
xe5di8kz
10 May 16
Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update
12:00am